IIM
ORKA

INTECH Investment Management’s Oruka Therapeutics ORKA Stock Holding History

INTECH Investment Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
11,763
+103
+0.9% +$6.86K 0.01% 974
2026
Q1 		$572K Sell
11,660
-3,153
-21% -$110K 0.01% 1275
2025
Q4 		$449K Buy
14,813
+2,307
+18% +$64.3K ﹤0.01% 1564
2025
Q3 		$240K Sell
12,506
-2,519
-17% -$37.3K ﹤0.01% 1952
2025
Q2 		$168K Buy
+15,025
New +$157K ﹤0.01% 2147

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

INTECH Investment Management's ORKA Position: Q2 2026 in Review

INTECH Investment Management increased its Oruka Therapeutics (ORKA) stake by 0.88% in Q2 2026, buying an estimated $6.86K and bringing the position to 11,763 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #974.

INTECH Investment Management first reported a position in ORKA in Q2 2025 and has held it in 5 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • INTECH Investment Management held 11,763 shares of Oruka Therapeutics worth $1.12M as of Q2 2026.
  • INTECH Investment Management bought 103 Oruka Therapeutics shares in Q2 2026, an estimated $6.86K.
  • Oruka Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #974 holding.
  • INTECH Investment Management first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.